Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...

Moderna’s stock has experienced a significant decline of 12.90% over the past week, reflecting investor concerns about the company’s recent financial performance and future prospects.

After soaring in early pandemic days, Moderna has fallen into the doldrums. An explosive phase of growth may be ahead thanks to several potential product launches. A lot can happen in 10 years ...

Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. On Monday, Moderna published ...

Moderna Stock Gains on Encouraging Flu Vaccine Data July 01, 2025 — 09:17 am EDT. ... MRNA Stock Price Performance. Post the above news, shares of Moderna rose nearly 2% yesterday.

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Moderna, Inc.

Moderna’s stock (NASDAQ: MRNA) has fallen over 80% in the last year, primarily due to issues with its vaccine sales. Last year, the company revealed reduced sales forecasts in Europe after the ...

Moderna, Pfizer and Merck stocks moved mostly sideways after RFK Jr. abruptly fired CDC's vaccine policy advisors. Investors are now waiting for news on how a reconstituted ACIP committee will ...